Skip to content

Author

V. Sayin

We have 2 of 77 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Selective and Synergistic Targeting of ErbB2-Positive Cancer Cells with ErbB2 Transmembrane Peptide-Ionic Liquid Nanocarrier Formulation.

Findings establish TM peptide-decorated SAIL nanocarriers as a promising strategy for selective and synergistic ErbB2-targeted cancer therapy for selective targeting of ErbB2-positive cancer cells.

Helal Abujubara, Pankaj Bharmoria, Dorota Raj et al. · 0 citations
Open access Jul 2026

STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesicles.

PD represents an accelerated aging disorder driven by STING-dependent inflammation, and LRRK2GoF is identified as a key driver of accelerated aging and systemic inflammaging through DNA-containing EVs, highlighting potential therapeutic targets to counteract inflammaging and neurodegeneration.

M. Öberg, Caitlyn Myers, Najmeh Saffarzadeh et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.